Justin Hanes, Ph.D.

Justin Hanes is a Venture Partner at Catalio Capital Management, LP.

Director, Center of Nanomedicine at Johns Hopkins Medicine

Nanomedicine

EDUCATION

BS – University of California Los Angeles

PhD – Massachusetts Institute of Technology

AWARDS AND ACCOLADES

National Academy of Inventors

The World’s Most Influential Scientific Minds / Highly Cited Researcher” by Thompson Reuters

MIT Technology Review 35 Innovators Under 35

COMPANIES AND BOARDS

Co-Founder: Kala Pharmaceuticals (NASDAQ: KALA), GrayBug Vision, Ashvattha Therapeutics, Orpheris, Theraly Fibrosis, Neuraly, Spiral Therapeutics, Advanced Inhalation Research (acquired by Alkermes), Civitas Therapeutics (acquired by Acorda)

MEMBER OF Investment Committee

Associated Portfolio Companies

Ashvattha Therapeutics
Orpheris
Perfuse Therapeutics
Spiral Therapeutics